Kimia Biosciences Ltd Financials
Company Logo

Kimia Biosciences Ltd Financial Statement

Kimia Biosciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue28.55
Operating Expense24.81
Net Profit1.61
Net Profit Margin5.64
Earning Per Share0.34
EBIDTA3.76
Effective Tax Rate8.56
Invest in Kimia Biosciences Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Kimia Biosciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue Annual128.52
Operating Expenses Annual133.49
Operating Profit Annual-4.81
Interest Annual4.25
Depreciation3.27
Net Profit Annual-9.35
Tax Annual-3.04

Kimia Biosciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Cash Flow at the Beginning0.20
Cash Flow from Operations-6.77
Cash Flow from Investing-2.80
Cash Flow from Financing9.54
Cash Flow at the End0.18

Kimia Biosciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
PBDIT Margin (%)-3.74
PBIT Margin (%)-6.33
PBT Margin (%)-4.84
Net PROFIT Margin (%)-7.28
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-14.26
Total Debt / Equity (X)4.60
Asset Turnover Ratio (%)1.96

Kimia Biosciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Fixed Assets Annual33.63
Total Current Assets Annual82.75
Non Current Assets Annual38.57
Total Shareholders Funds Annual5.46
Total Assets Annual121.32

Kimia Biosciences Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 24, 2024, Kimia Biosciences Ltd has a market capitalization of 263.67 Cr. Value Research classifies it as a Small-Cap company.
No, Kimia Biosciences Ltd is not debt-free with a debt-to-equity ratio of 132.05.
In FY 2023 , Kimia Biosciences Ltd recorded a total revenue of approximately 104.88 Cr marking a significant milestone in the company's financial performance.
Kimia Biosciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and -0.1% annually, respectively..
Kimia Biosciences Ltd's current PE ratio is -49.66.
Kimia Biosciences Ltd's ROCE averaged -6.3% from the FY ending March 2022 to 2024, with a median of -4.2%. It peaked at -2.2% in March 2022, reflecting strong capital efficiency over the period..
Kimia Biosciences Ltd's latest EBIT is Rs. -2.13 Cr, surpassing the average EBIT of Rs. -3.88 Cr over the 5 years..